(0.28%) 5 561.75 points
(0.04%) 39 565 points
(0.43%) 20 125 points
(0.62%) $82.25
(0.86%) $2.71
(0.05%) $2 337.70
(0.70%) $29.46
(1.88%) $1 010.30
(0.13%) $0.935
(0.41%) $10.67
(0.04%) $0.791
(1.74%) $86.48
2.88% HKD 3.22
Live Chart Being Loaded With Signals
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China...
Stats | |
---|---|
Dzisiejszy wolumen | 4 000 |
Średni wolumen | 106 595 |
Kapitalizacja rynkowa | 1.66B |
EPS | HKD-0.210 ( Q4 | 2023-12-31 ) |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E |
-4.60 (Sector) 14.27 (Industry) 6.31 |
ATR14 | HKD0 (0.00%) |
Immunotech Biopharm Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immunotech Biopharm Ltd Finanse
Annual | 2023 |
Przychody: | HKD0 |
Zysk brutto: | HKD0 (0.00 %) |
EPS: | HKD-0.650 |
FY | 2023 |
Przychody: | HKD0 |
Zysk brutto: | HKD0 (0.00 %) |
EPS: | HKD-0.650 |
FY | 2022 |
Przychody: | HKD0 |
Zysk brutto: | HKD0 (0.00 %) |
EPS: | HKD-0.690 |
FY | 2021 |
Przychody: | HKD0.00 |
Zysk brutto: | HKD0.00 (0.00 %) |
EPS: | HKD-0.708 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Immunotech Biopharm Ltd
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia; and TCR-T cell series products to treat solid tumors. The company was founded in 2006 and is headquartered in Beijing, the People's Republic of China.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej